91Indexed trials
Market Rank #23 · Evidence Tier A
Austria
Neuroscience Intelligence
Austria neuroscience intelligence: 91 indexed trials, 25 institutions, research score 32.98.
28Recruiting
25Research institutions
33.0Research score
Evidence profile
61Sponsors
20Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 33 · ML priority 33 · Confidence 100 · Evidence 33.0
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
parkinsons22trials
epilepsy11trials
alzheimers9trials
neuro_oncology5trials
depression5trials
stroke5trials
other_neurology3trials
schizophrenia3trials
adhd3trials
multiple_sclerosis3trials
Leading indexed sponsors
Medical University of Vienna7trials
Boehringer Ingelheim6trials
Merck Sharp & Dohme LLC5trials
Hoffmann-La Roche5trials
Bayer3trials
NORCE Norwegian Research Centre AS2trials
Newron Pharmaceuticals SPA2trials
JANSSEN Alzheimer Immunotherapy Research & Development, LLC2trials
AbbVie2trials
Novartis Pharmaceuticals2trials